Research

Development and Translation of Novel Host Defense Peptides for Acanthamoeba Keratitis

Development of novel antimicrobial therapy for Acanthamoeba Keratitis

Researchers seek to develop novel HDPs with enhanced efficacy and safety to treat Acanthamoeba Keratitis (AK).

Why is Acanthamoeba keratitis on the rise?

Understanding the causes of an emerging threat to sight.

Acanthamoeba under the microscope

Finding out who will need longer treatment to save their sight.

Identifying genetic causes leading to Keratitis infection in UK patients

The aim of the study is to determine whether different types of isolates respond differently to drugs used to prevent or treat Acanthamoeba infection.